Incyte (NASDAQ: INCY) and China-based Innovent Biologics, Inc. (Innovent) announced a strategic collaboration agreement for three clinical-stage product candidates discovered and developed by Incyte, including: Pemigratiniib (FGFR 1/2/3 inhibitor) Itacitinib (JAK1...
Hemotology
Category
TrialWatch: Novimmune’s Emapalumab May Treat Primary Hemophagocytic Lymphohistiocytosis
Novimmune’s Emapalumab could be a promising new therapeutic option for patients with primary hemophagocytic lymphohistiocytosis (pHLH). Results of the study were presented at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition, December 1-4...
MD Anderson Collaborates with Jazz Pharmaceuticals to Evaluate Hematol Treatment Options
EurekAlert! Reports MD Anderson press release on a five-year strategic partnership between MD Anderson and Jazz Pharmaceuticals plc with targeted goal of evaluating therapies for multiple hematologic malignancies, including, including acute myeloid leukemia (AML) and...